Pharmaceutical design of a delivery system for the bacteriocin lacticin 3147 View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-04-19

AUTHORS

Aoibhín Ryan, Pratikkumar Patel, Paula M. O’Connor, R. Paul Ross, Colin Hill, Sarah P. Hudson

ABSTRACT

Lacticin 3147 is a dual-acting two-peptide bacteriocin which is generally active against Gram-positive bacteria, including Listeria monocytogenes and antimicrobial-resistant bacteria such as Closteroides difficile in the colon. L. monocytogenes infections can cause life-long effects in the elderly and vulnerable and can cause severe complications in pregnant women. C. difficile causes one of the most common healthcare-associated infections and can be fatal in vulnerable groups such as the elderly. Although lacticin 3147 is degraded by intestinal proteases and has poor aqueous solubility, encapsulation of the bacteriocin could enable its use as an antimicrobial for treating these bacterial infections locally in the gastrointestinal tract. Lacticin 3147 displayed activity in aqueous solutions at a range of pH values and in gastric and intestinal fluids. Exposure to trypsin and α-chymotrypsin resulted in complete inactivation, implying that lacticin 3147 should be protected from these enzymes to achieve successful local delivery to the gastrointestinal tract. The amount of lacticin 3147 dissolved, i.e. its solution concentration, in water or buffered solutions at pH 1.6 and 7.4 was low and varied with time but increased and was stabilized in gastrointestinal fluids by the phospholipid and bile salt components present. Thus, the feasibility of a solid lipid nanoparticle (SLN) delivery system for local administration of lacticin 3147 was investigated. Bacteriocin activity was observed after encapsulation and release from a lipid matrix. Moreover, activity was seen after exposure to degrading enzymes. Further optimization of SLN delivery systems could enable the successful pharmaceutical development of active lacticin 3147 as an alternative to traditional antibiotics.Graphical abstract More... »

PAGES

1735-1751

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13346-021-00984-9

DOI

http://dx.doi.org/10.1007/s13346-021-00984-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1137309409

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/33876405


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Microbiology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bacteriocins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clostridioides difficile", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liposomes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Listeria monocytogenes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanoparticles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pregnancy", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland", 
          "id": "http://www.grid.ac/institutes/grid.10049.3c", 
          "name": [
            "Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ryan", 
        "givenName": "Aoibh\u00edn", 
        "id": "sg:person.013233154414.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013233154414.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland", 
          "id": "http://www.grid.ac/institutes/grid.10049.3c", 
          "name": [
            "Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Patel", 
        "givenName": "Pratikkumar", 
        "id": "sg:person.01051343520.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051343520.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "APC Microbiome Ireland Cork, Cork, Ireland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Teagasc Food Research Centre Moorepark, Fermoy Co. Cork, Fermoy, Ireland", 
            "APC Microbiome Ireland Cork, Cork, Ireland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "O\u2019Connor", 
        "givenName": "Paula M.", 
        "id": "sg:person.0721110445.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721110445.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Microbiology, University College Cork, College Road, Cork, Ireland", 
          "id": "http://www.grid.ac/institutes/grid.7872.a", 
          "name": [
            "APC Microbiome Ireland Cork, Cork, Ireland", 
            "School of Microbiology, University College Cork, College Road, Cork, Ireland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ross", 
        "givenName": "R. Paul", 
        "id": "sg:person.014605670062.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014605670062.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Microbiology, University College Cork, College Road, Cork, Ireland", 
          "id": "http://www.grid.ac/institutes/grid.7872.a", 
          "name": [
            "APC Microbiome Ireland Cork, Cork, Ireland", 
            "School of Microbiology, University College Cork, College Road, Cork, Ireland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hill", 
        "givenName": "Colin", 
        "id": "sg:person.01202224511.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202224511.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "SSPC the SFI Research Centre for Pharmaceuticals, University of Limerick, Limerick, Ireland", 
          "id": "http://www.grid.ac/institutes/grid.10049.3c", 
          "name": [
            "Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland", 
            "SSPC the SFI Research Centre for Pharmaceuticals, University of Limerick, Limerick, Ireland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hudson", 
        "givenName": "Sarah P.", 
        "id": "sg:person.01251463043.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251463043.49"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s12602-013-9125-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039954846", 
          "https://doi.org/10.1007/s12602-013-9125-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrmicro2937", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036017430", 
          "https://doi.org/10.1038/nrmicro2937"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13346-012-0088-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003160531", 
          "https://doi.org/10.1007/s13346-012-0088-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13346-015-0267-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008681992", 
          "https://doi.org/10.1007/s13346-015-0267-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1018961227717", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031550459", 
          "https://doi.org/10.1023/a:1018961227717"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1011032328064", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045411427", 
          "https://doi.org/10.1023/a:1011032328064"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1741-7007-8-123", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039878272", 
          "https://doi.org/10.1186/1741-7007-8-123"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrmicro.2017.126", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1093028069", 
          "https://doi.org/10.1038/nrmicro.2017.126"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1208/s12248-014-9688-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011897050", 
          "https://doi.org/10.1208/s12248-014-9688-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1016473601633", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025211964", 
          "https://doi.org/10.1023/a:1016473601633"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-04-19", 
    "datePublishedReg": "2021-04-19", 
    "description": "Lacticin 3147 is a dual-acting two-peptide bacteriocin which is generally active against Gram-positive bacteria, including Listeria monocytogenes and antimicrobial-resistant bacteria such as Closteroides difficile in the colon. L. monocytogenes infections can cause life-long effects in the elderly and vulnerable and can cause severe complications in pregnant women. C. difficile causes one of the most common healthcare-associated infections and can be fatal in vulnerable groups such as the elderly. Although lacticin 3147 is degraded by intestinal proteases and has poor aqueous solubility, encapsulation of the bacteriocin could enable its use as an antimicrobial for treating these bacterial infections locally in the gastrointestinal tract. Lacticin 3147 displayed activity in aqueous solutions at a range of pH values and in gastric and intestinal fluids. Exposure to trypsin and \u03b1-chymotrypsin resulted in complete inactivation, implying that lacticin 3147 should be protected from these enzymes to achieve successful local delivery to the gastrointestinal tract. The amount of lacticin 3147 dissolved, i.e. its solution concentration, in water or buffered solutions at pH 1.6 and 7.4 was low and varied with time but increased and was stabilized in gastrointestinal fluids by the phospholipid and bile salt components present. Thus, the feasibility of a solid lipid nanoparticle (SLN) delivery system for local administration of lacticin 3147 was investigated. Bacteriocin activity was observed after encapsulation and release from a lipid matrix. Moreover, activity was seen after exposure to degrading enzymes. Further optimization of SLN delivery systems could enable the successful pharmaceutical development of active lacticin 3147 as an alternative to traditional antibiotics.Graphical abstract", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13346-021-00984-9", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1044116", 
        "issn": [
          "2190-393X", 
          "2190-3948"
        ], 
        "name": "Drug Delivery and Translational Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "keywords": [
      "gastrointestinal tract", 
      "Solid lipid nanoparticle (SLN) delivery systems", 
      "common healthcare-associated infections", 
      "L. monocytogenes infection", 
      "healthcare-associated infections", 
      "SLN delivery systems", 
      "successful pharmaceutical development", 
      "life-long effects", 
      "severe complications", 
      "lipid nanoparticle delivery systems", 
      "delivery system", 
      "pregnant women", 
      "monocytogenes infection", 
      "bacterial infections", 
      "C. difficile", 
      "antimicrobial-resistant bacteria", 
      "local delivery", 
      "poor aqueous solubility", 
      "nanoparticle delivery system", 
      "infection", 
      "intestinal proteases", 
      "local administration", 
      "vulnerable groups", 
      "tract", 
      "intestinal fluid", 
      "gastrointestinal fluids", 
      "traditional antibiotics", 
      "Listeria monocytogenes", 
      "exposure", 
      "Gram-positive bacteria", 
      "lacticin 3147", 
      "pharmaceutical development", 
      "complications", 
      "colon", 
      "bacteriocin activity", 
      "administration", 
      "difficile", 
      "activity", 
      "women", 
      "antibiotics", 
      "aqueous solubility", 
      "pharmaceutical design", 
      "antimicrobials", 
      "bacteriocin", 
      "bacteriocin lacticin 3147", 
      "delivery", 
      "enzyme", 
      "two-peptide bacteriocin", 
      "group", 
      "fluid", 
      "bacteria", 
      "monocytogenes", 
      "release", 
      "complete inactivation", 
      "inactivation", 
      "lipid matrix", 
      "protease", 
      "trypsin", 
      "effect", 
      "further optimization", 
      "concentration", 
      "use", 
      "buffered solution", 
      "development", 
      "feasibility", 
      "alternative", 
      "time", 
      "\u03b1-chymotrypsin", 
      "system", 
      "values", 
      "amount", 
      "components", 
      "encapsulation", 
      "range", 
      "design", 
      "aqueous solution", 
      "solubility", 
      "solution concentration", 
      "salt components", 
      "matrix", 
      "water", 
      "solution", 
      "Dissolved", 
      "optimization"
    ], 
    "name": "Pharmaceutical design of a delivery system for the bacteriocin lacticin 3147", 
    "pagination": "1735-1751", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1137309409"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13346-021-00984-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "33876405"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13346-021-00984-9", 
      "https://app.dimensions.ai/details/publication/pub.1137309409"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-10T10:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_881.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13346-021-00984-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13346-021-00984-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13346-021-00984-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13346-021-00984-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13346-021-00984-9'


 

This table displays all metadata directly associated to this object as RDF triples.

271 TRIPLES      22 PREDICATES      130 URIs      112 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13346-021-00984-9 schema:about N05c2f43a030f479284e3c9c23ccb31cb
2 N07ede576f4454c0794b8b736866e9b94
3 N2e1521bf1f654318bd1bc7eabf14c84b
4 N322911e217cf40bdb4942a0f667a8320
5 N4f3735a171114ea484d911a38a5857ef
6 N5467b032c2e045ddb9f49fb2142a8d99
7 N8c81ff5826ad490f825d84e7faacbdfb
8 N8e1d2a3255b34c158ce13f3bef73e3f8
9 N931b81331122461584b7e1d66c1990e4
10 Nea4271c357774b9a981406a2dbeba4a1
11 anzsrc-for:11
12 anzsrc-for:1108
13 schema:author N3b9fd21ed9f2401d9e3b938d5bca94ea
14 schema:citation sg:pub.10.1007/s12602-013-9125-3
15 sg:pub.10.1007/s13346-012-0088-9
16 sg:pub.10.1007/s13346-015-0267-6
17 sg:pub.10.1023/a:1011032328064
18 sg:pub.10.1023/a:1016473601633
19 sg:pub.10.1023/a:1018961227717
20 sg:pub.10.1038/nrmicro.2017.126
21 sg:pub.10.1038/nrmicro2937
22 sg:pub.10.1186/1741-7007-8-123
23 sg:pub.10.1208/s12248-014-9688-2
24 schema:datePublished 2021-04-19
25 schema:datePublishedReg 2021-04-19
26 schema:description Lacticin 3147 is a dual-acting two-peptide bacteriocin which is generally active against Gram-positive bacteria, including Listeria monocytogenes and antimicrobial-resistant bacteria such as Closteroides difficile in the colon. L. monocytogenes infections can cause life-long effects in the elderly and vulnerable and can cause severe complications in pregnant women. C. difficile causes one of the most common healthcare-associated infections and can be fatal in vulnerable groups such as the elderly. Although lacticin 3147 is degraded by intestinal proteases and has poor aqueous solubility, encapsulation of the bacteriocin could enable its use as an antimicrobial for treating these bacterial infections locally in the gastrointestinal tract. Lacticin 3147 displayed activity in aqueous solutions at a range of pH values and in gastric and intestinal fluids. Exposure to trypsin and α-chymotrypsin resulted in complete inactivation, implying that lacticin 3147 should be protected from these enzymes to achieve successful local delivery to the gastrointestinal tract. The amount of lacticin 3147 dissolved, i.e. its solution concentration, in water or buffered solutions at pH 1.6 and 7.4 was low and varied with time but increased and was stabilized in gastrointestinal fluids by the phospholipid and bile salt components present. Thus, the feasibility of a solid lipid nanoparticle (SLN) delivery system for local administration of lacticin 3147 was investigated. Bacteriocin activity was observed after encapsulation and release from a lipid matrix. Moreover, activity was seen after exposure to degrading enzymes. Further optimization of SLN delivery systems could enable the successful pharmaceutical development of active lacticin 3147 as an alternative to traditional antibiotics.Graphical abstract
27 schema:genre article
28 schema:inLanguage en
29 schema:isAccessibleForFree true
30 schema:isPartOf N3dc6f3b0727d48ea98d9b5ffb975eed6
31 Ne2d553046ba1435e8e63945b2e5a32cd
32 sg:journal.1044116
33 schema:keywords C. difficile
34 Dissolved
35 Gram-positive bacteria
36 L. monocytogenes infection
37 Listeria monocytogenes
38 SLN delivery systems
39 Solid lipid nanoparticle (SLN) delivery systems
40 activity
41 administration
42 alternative
43 amount
44 antibiotics
45 antimicrobial-resistant bacteria
46 antimicrobials
47 aqueous solubility
48 aqueous solution
49 bacteria
50 bacterial infections
51 bacteriocin
52 bacteriocin activity
53 bacteriocin lacticin 3147
54 buffered solution
55 colon
56 common healthcare-associated infections
57 complete inactivation
58 complications
59 components
60 concentration
61 delivery
62 delivery system
63 design
64 development
65 difficile
66 effect
67 encapsulation
68 enzyme
69 exposure
70 feasibility
71 fluid
72 further optimization
73 gastrointestinal fluids
74 gastrointestinal tract
75 group
76 healthcare-associated infections
77 inactivation
78 infection
79 intestinal fluid
80 intestinal proteases
81 lacticin 3147
82 life-long effects
83 lipid matrix
84 lipid nanoparticle delivery systems
85 local administration
86 local delivery
87 matrix
88 monocytogenes
89 monocytogenes infection
90 nanoparticle delivery system
91 optimization
92 pharmaceutical design
93 pharmaceutical development
94 poor aqueous solubility
95 pregnant women
96 protease
97 range
98 release
99 salt components
100 severe complications
101 solubility
102 solution
103 solution concentration
104 successful pharmaceutical development
105 system
106 time
107 tract
108 traditional antibiotics
109 trypsin
110 two-peptide bacteriocin
111 use
112 values
113 vulnerable groups
114 water
115 women
116 α-chymotrypsin
117 schema:name Pharmaceutical design of a delivery system for the bacteriocin lacticin 3147
118 schema:pagination 1735-1751
119 schema:productId Nc479b6cc7cb74657a52f172c5d00506b
120 Nef8600f312bc4ca6b8d2925da72cb495
121 Nff6ad725cffa40f295b96ce89ce25c6c
122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1137309409
123 https://doi.org/10.1007/s13346-021-00984-9
124 schema:sdDatePublished 2022-05-10T10:30
125 schema:sdLicense https://scigraph.springernature.com/explorer/license/
126 schema:sdPublisher N2d535fd6f2d8467e846a15ec215036f4
127 schema:url https://doi.org/10.1007/s13346-021-00984-9
128 sgo:license sg:explorer/license/
129 sgo:sdDataset articles
130 rdf:type schema:ScholarlyArticle
131 N05c2f43a030f479284e3c9c23ccb31cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Aged
133 rdf:type schema:DefinedTerm
134 N07ede576f4454c0794b8b736866e9b94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Humans
136 rdf:type schema:DefinedTerm
137 N2d535fd6f2d8467e846a15ec215036f4 schema:name Springer Nature - SN SciGraph project
138 rdf:type schema:Organization
139 N2e1521bf1f654318bd1bc7eabf14c84b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Liposomes
141 rdf:type schema:DefinedTerm
142 N322911e217cf40bdb4942a0f667a8320 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Pregnancy
144 rdf:type schema:DefinedTerm
145 N37935a9533324f8091b8043c2bb73671 rdf:first sg:person.01051343520.17
146 rdf:rest N9bc9a216d5d546ffa2f096bcdc7af011
147 N3b9fd21ed9f2401d9e3b938d5bca94ea rdf:first sg:person.013233154414.97
148 rdf:rest N37935a9533324f8091b8043c2bb73671
149 N3dc6f3b0727d48ea98d9b5ffb975eed6 schema:volumeNumber 11
150 rdf:type schema:PublicationVolume
151 N4f3735a171114ea484d911a38a5857ef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Clostridioides difficile
153 rdf:type schema:DefinedTerm
154 N5467b032c2e045ddb9f49fb2142a8d99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Listeria monocytogenes
156 rdf:type schema:DefinedTerm
157 N8c81ff5826ad490f825d84e7faacbdfb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Drug Design
159 rdf:type schema:DefinedTerm
160 N8e1d2a3255b34c158ce13f3bef73e3f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Bacteriocins
162 rdf:type schema:DefinedTerm
163 N931b81331122461584b7e1d66c1990e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Female
165 rdf:type schema:DefinedTerm
166 N9bc9a216d5d546ffa2f096bcdc7af011 rdf:first sg:person.0721110445.25
167 rdf:rest Nab0c179dff1446cf812584a02fb51b57
168 Nab0c179dff1446cf812584a02fb51b57 rdf:first sg:person.014605670062.43
169 rdf:rest Nbf4b89dc19154755ac43ffe528351fba
170 Nbf4b89dc19154755ac43ffe528351fba rdf:first sg:person.01202224511.99
171 rdf:rest Nfa02c3d44b4c4890b8c269c4e937bd79
172 Nc479b6cc7cb74657a52f172c5d00506b schema:name pubmed_id
173 schema:value 33876405
174 rdf:type schema:PropertyValue
175 Ne2d553046ba1435e8e63945b2e5a32cd schema:issueNumber 4
176 rdf:type schema:PublicationIssue
177 Nea4271c357774b9a981406a2dbeba4a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Nanoparticles
179 rdf:type schema:DefinedTerm
180 Nef8600f312bc4ca6b8d2925da72cb495 schema:name doi
181 schema:value 10.1007/s13346-021-00984-9
182 rdf:type schema:PropertyValue
183 Nfa02c3d44b4c4890b8c269c4e937bd79 rdf:first sg:person.01251463043.49
184 rdf:rest rdf:nil
185 Nff6ad725cffa40f295b96ce89ce25c6c schema:name dimensions_id
186 schema:value pub.1137309409
187 rdf:type schema:PropertyValue
188 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
189 schema:name Medical and Health Sciences
190 rdf:type schema:DefinedTerm
191 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
192 schema:name Medical Microbiology
193 rdf:type schema:DefinedTerm
194 sg:journal.1044116 schema:issn 2190-393X
195 2190-3948
196 schema:name Drug Delivery and Translational Research
197 schema:publisher Springer Nature
198 rdf:type schema:Periodical
199 sg:person.01051343520.17 schema:affiliation grid-institutes:grid.10049.3c
200 schema:familyName Patel
201 schema:givenName Pratikkumar
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051343520.17
203 rdf:type schema:Person
204 sg:person.01202224511.99 schema:affiliation grid-institutes:grid.7872.a
205 schema:familyName Hill
206 schema:givenName Colin
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202224511.99
208 rdf:type schema:Person
209 sg:person.01251463043.49 schema:affiliation grid-institutes:grid.10049.3c
210 schema:familyName Hudson
211 schema:givenName Sarah P.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251463043.49
213 rdf:type schema:Person
214 sg:person.013233154414.97 schema:affiliation grid-institutes:grid.10049.3c
215 schema:familyName Ryan
216 schema:givenName Aoibhín
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013233154414.97
218 rdf:type schema:Person
219 sg:person.014605670062.43 schema:affiliation grid-institutes:grid.7872.a
220 schema:familyName Ross
221 schema:givenName R. Paul
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014605670062.43
223 rdf:type schema:Person
224 sg:person.0721110445.25 schema:affiliation grid-institutes:None
225 schema:familyName O’Connor
226 schema:givenName Paula M.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721110445.25
228 rdf:type schema:Person
229 sg:pub.10.1007/s12602-013-9125-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039954846
230 https://doi.org/10.1007/s12602-013-9125-3
231 rdf:type schema:CreativeWork
232 sg:pub.10.1007/s13346-012-0088-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003160531
233 https://doi.org/10.1007/s13346-012-0088-9
234 rdf:type schema:CreativeWork
235 sg:pub.10.1007/s13346-015-0267-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008681992
236 https://doi.org/10.1007/s13346-015-0267-6
237 rdf:type schema:CreativeWork
238 sg:pub.10.1023/a:1011032328064 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045411427
239 https://doi.org/10.1023/a:1011032328064
240 rdf:type schema:CreativeWork
241 sg:pub.10.1023/a:1016473601633 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025211964
242 https://doi.org/10.1023/a:1016473601633
243 rdf:type schema:CreativeWork
244 sg:pub.10.1023/a:1018961227717 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031550459
245 https://doi.org/10.1023/a:1018961227717
246 rdf:type schema:CreativeWork
247 sg:pub.10.1038/nrmicro.2017.126 schema:sameAs https://app.dimensions.ai/details/publication/pub.1093028069
248 https://doi.org/10.1038/nrmicro.2017.126
249 rdf:type schema:CreativeWork
250 sg:pub.10.1038/nrmicro2937 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036017430
251 https://doi.org/10.1038/nrmicro2937
252 rdf:type schema:CreativeWork
253 sg:pub.10.1186/1741-7007-8-123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039878272
254 https://doi.org/10.1186/1741-7007-8-123
255 rdf:type schema:CreativeWork
256 sg:pub.10.1208/s12248-014-9688-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011897050
257 https://doi.org/10.1208/s12248-014-9688-2
258 rdf:type schema:CreativeWork
259 grid-institutes:None schema:alternateName APC Microbiome Ireland Cork, Cork, Ireland
260 schema:name APC Microbiome Ireland Cork, Cork, Ireland
261 Teagasc Food Research Centre Moorepark, Fermoy Co. Cork, Fermoy, Ireland
262 rdf:type schema:Organization
263 grid-institutes:grid.10049.3c schema:alternateName Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland
264 SSPC the SFI Research Centre for Pharmaceuticals, University of Limerick, Limerick, Ireland
265 schema:name Department of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland
266 SSPC the SFI Research Centre for Pharmaceuticals, University of Limerick, Limerick, Ireland
267 rdf:type schema:Organization
268 grid-institutes:grid.7872.a schema:alternateName School of Microbiology, University College Cork, College Road, Cork, Ireland
269 schema:name APC Microbiome Ireland Cork, Cork, Ireland
270 School of Microbiology, University College Cork, College Road, Cork, Ireland
271 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...